glp-1 and hs drugs linked to reduced symptoms in chronic skin condition hidradenitis suppurativa Exploring the Therapeutic Potential of
Description
B.ChristensenH
However, the catabolic qualities of glucagon, notably its effect to decrease hepatic fat and circulating lipids, could be leveraged for therapeutic benefit in metabolic diseases if its diabetogenic action were mitigated
Men often carry weight differently than women, with more visceral fat around the abdomen, which can be more difficult to lose through diet and exercise alone
A recent cohort study involving 200 IBD patients identified visceral adiposity, rather than BMI, as a predictive risk factor for a shorter time to IBD flare, particularly for CD patients (90)
On an empty stomach : Some users report that taking their injection without eating enough in the days before can worsen GI symptoms
The findings revealed that the benefits of GLP-1 RAs remained consistent across both time periods, unaffected by the chronological changes
